Dr Francesco Granata has over 35 years’ experience in biopharmaceuticals, private equity, venture capital and board management. He is a senior advisor at Warburg Pincus International LLC and Chairman of Circassia Plc and a Board member of Italfarmaco, Prismic Pharmaceuticals and Quanta Ltd.
Dr Granata has served as a member of the Executive Committee at Biogen Idec (NASDAQ: BIIB), where he led global commercial and medical affairs until 2012, and as Group Vice President for Schering-Plough Europe and Canada. He has previously held senior management positions with Pfizer, Pharmacia and Dompѐ Biotec and a commercial management position with GlaxoSmithKline Plc. Dr Granata started his pharmaceutical career in research and development.